RPS Conference 2010, Abstracts 2010 - Royal Pharmaceutical Society

More documents

Recommendations

Info

not influence the administration of as required medication. Neither the H 1 nor D 2 receptor affinity of the regular antipsychotic predicted the use of a regular benzodiazepine or hypnotic. This suggests that patients using large amounts of as required medication should be considered for an antipsychotic with higher H 1 receptor affinity. Acknowledgement: The authors wish to thank Mrs W Davies for the opportunity to conduct this work. References: 1. CSM advice CEM/CMO/2004/1 Banerjee S, The use of antipsychotic medication for people with dementia: time for action. Department of Health, November 2009
51 Using simulation of community pharmacy practice to assess pharmacists whose performance has given cause for concern Pauline McAvoy 1 , Nicholas Brown 1 , Martin Rhodes 1 , William Rial 1 , Delic Jelena 2 , Cowan Louise 2 1 National Clinical Assessment Service (NCAS), London, United Kingdom, 2 School of Pharmacy, University of Hertfordshire, Hertfordshire, United Kingdom Focal Points • The paper describes how a high fidelity simulation session was developed for community pharmacists. • Its use is for pharmacists who have concerns about their performance but cannot be observed in their workplace. • The challenges this presented were identified and overcome • The outcome is a valid and practical assessment. Introduction The National Clinical Assessment Service (NCAS) helps employers in the UK manage performance concerns in doctors, dentists and pharmacists(1). When advice and support fails to resolve the concerns a holistic workplace based assessment may be conducted to help define the issues and to provide the basis for remediation. Along with the technical aspects of the practitioner’s work, an NCAS assessment considers the practitioner / patient relationship, working with colleagues and record keeping taking into account the work environment, The practitioner’s health and behavioural characteristics are also assessed (2). A core component of the assessment is direct observation of practice. Many community pharmacists are peripatetic locums and others may have been suspended from practice, making observation in the workplace impossible. The aim was to produce a high fidelity simulation of pharmacy practice to enable the assessment of clinical practice when direct observation is not feasible. Method A multidisciplinary team consisting of NCAS specialists, pharmacy academics and a freelance media director worked over six months to develop 50 scenarios that a community pharmacist could expect to encounter frequently along with a range of scenarios that would test the pharmacist’s response to issues of patient safety. This involved training a group of actors as simulated patients / customers and designing two, three hour simulated community pharmacy practice sessions to reflect the scope of practice of each of the individual volunteer community pharmacists. The pilot assessments were hosted at the simulated pharmacy unit in the Clinical Skills Centre at the University of Hertfordshire. Two community pharmacists volunteered to be assessed. To ensure the face validity of the pharmacy environment, a pharmacy technician and counter assistant were recruited and briefed on the purpose of the exercise and asked to work as team members of the pharmacists being assessed. A pilot session was filmed which enabled the team to familiarise themselves with the pharmacy and refine the scenarios and for further use to train assessors. For each of the three hour sessions, 25 scenarios were used with patients / customers often appearing together as they would do in real practice requiring the pharmacists being assessed to prioritise and multi-task. NCAS assessors recorded their judgements using standard NCAS observation of practice instruments.
Page 1 and 2:
1 Cost effectiveness of community p
Page 3 and 4:
2 The Diabetes Pilot Program: Barri
Page 5 and 6:
3 The PINCER trial: a cluster rando
Page 7 and 8:
4 How pharmacists working on the PI
Page 9 and 10:
5 A systematic review of weight man
Page 11 and 12:
6 An exploration of the potential i
Page 13 and 14:
7 An Exploration of Nursing Home Ma
Page 15 and 16:
8 Unintended discrepancies between
Page 17 and 18:
9 Unlicensed Medicines: Risk and Re
Page 19 and 20:
10 Audit of Discharge Summaries in
Page 21 and 22:
11 Over-the-counter simvastatin: co
Page 23 and 24:
12 A qualitative study of disadvant
Page 25 and 26:
13 Pharmacist prescribing in North
Page 27 and 28:
14 Pharmacist prescribing in primar
Page 29 and 30:
15 Training undergraduate pharmacy
Page 31 and 32:
16 ‘You’re an agent unto yourse
Page 33 and 34:
17 Information for young people wit
Page 35 and 36:
18 The Role of the Pharmacist and E
Page 37 and 38:
19 Exploring patient opinions of MU
Page 39 and 40:
20 Why do patients accept or declin
Page 41 and 42:
21 Further investigations on GP pre
Page 43 and 44:
22 The HAPPY trial: a randomised co
Page 45 and 46:
23 The effects of numeracy on the p
Page 47 and 48:
24 Translation and evaluation of
Page 49 and 50: 25 Influence of relationships, trus
Page 51 and 52: 26 Title: Pharmacists’ well being
Page 53 and 54: 27 What do newly qualified pharmaci
Page 55 and 56: 28 Does learning the “pure” sci
Page 57 and 58: 29 Defining and identifying perform
Page 59 and 60: 30 Engendering and Appraising ‘Pr
Page 61 and 62: 31 Inappropriate prescribing of Opi
Page 63 and 64: 32 Developing a five-year curriculu
Page 65 and 66: 33 An Investigation of the incidenc
Page 67 and 68: 34 Analysing medicine wastage in th
Page 69 and 70: 35 A Clinical Audit on the Use of A
Page 71 and 72: 36 A Clinical Audit on Reporting an
Page 73 and 74: 37 Assessment of hypertension care
Page 75 and 76: 38 Community pharmacy EHC services:
Page 77 and 78: 39 The Impact of the Lloyds Pharmac
Page 79 and 80: 40 Medication and handover incident
Page 81 and 82: 41 The time-scale for delivery of p
Page 83 and 84: 42 Medication access in primary car
Page 85 and 86: 43 A solution to improving uptake o
Page 87 and 88: 44 Medicines Information to Support
Page 89 and 90: 45 Are pharmacist public health pra
Page 91 and 92: 46 Anticoagulation for haemofiltrat
Page 93 and 94: 47 Med Wreck: An Audit of Communica
Page 95 and 96: 48 Pandemic flu preparedness: Plann
Page 97 and 98: 49 Young people's views about chlam
Page 99: 50 Psychotropic use in elderly pati
Page 103 and 104: 52 ‘Pharmacists in Schools’: De
Page 105 and 106: 53 What do Pharmacists in Surrey wa
Page 107 and 108: 54 Has the new audit module in the
Page 109 and 110: 55 Introduction of a Nursing Home B
Page 111 and 112: 56 An audit of Benzodiazepine presc
Page 113 and 114: 57 Improving patient safety through
Page 115 and 116: 58 Video clips enhance student lear
Page 117 and 118: 59 Do preregistration trainee pharm
Page 119 and 120: 60 An investigation of the views of
Page 121 and 122: 61 Ensuring accuracy in routinely c
Page 123 and 124: 62 Deprivation status and utilizati
Page 125 and 126: 63 Exploring Reasons, Factors and A
Page 127 and 128: 64 I’m off to the gym: Exploring
Page 129 and 130: 65 Is there alignment between the v
Page 131 and 132: 66 The views of out-patients with c
Page 133 and 134: 67 Patient Experiences of Living wi
Page 135 and 136: 68 Clinical management and cost of
Page 137 and 138: 69 Medicines Use Reviews - how have
Page 139 and 140: 70 How are pharmacists, registered
Page 141 and 142: 71 Barriers facing hypertensive pat
Page 143 and 144: 72 Developing an RCT of general pra
Page 145 and 146: 73 User and Staff Perspectives of C
Page 147 and 148: 74 Impact of pandemic influenza A/H
Page 149 and 150: 75 How do patients with osteoporosi
Page 151 and 152:
76 Integrating tuberculosis and dia
Page 153 and 154:
77 Improving outcomes and quality o
Page 155 and 156:
78 The uncertain future: a pilot st
Page 157 and 158:
79 Linkage of routinely collected N
Page 159 and 160:
80 Impact of Formative Assessment o
Page 161 and 162:
81 The prevalence of pharmacists’
Page 163 and 164:
82 A comparative study of prescribi
Page 165 and 166:
83 Evaluation of patient informatio
Page 167 and 168:
84 Patient medication adherence: a
Page 169 and 170:
85 Fitness to practise: pharmacists
Page 171 and 172:
86 Measurement of empathy levels in
Page 173 and 174:
87 Benzyl Alcohol Exposure from Hep
Page 175 and 176:
88 Neonatal gentamicin infusions- W
Page 177 and 178:
89 Unlicensed and off-label use of
Page 179 and 180:
90 Unlicensed and off-label prescri
Page 181 and 182:
91 Exploring community pharmacists
Page 183 and 184:
92 Investigation into Rapid Microbi
Page 185 and 186:
93 Pharmacy prescribing in XXXX-a q
Page 187 and 188:
94 Pharmacy prescribing in XXXX-a q
Page 189 and 190:
95 MEDICINE RELATED PROBLEMS IN SOU
Page 191 and 192:
96 Stability of pharmaceutical prod
Page 193 and 194:
97 The experiences of Malaysian pha
Page 195 and 196:
98 Medication management in older p
Page 197 and 198:
99 Adherence with calcium and vitam
Page 199 and 200:
100 Appraisal systems within commun
Page 201 and 202:
101 The clinical impact of a fractu
Page 203 and 204:
102 An audit of primary care prescr
Page 205 and 206:
103 Views of the public on over-the
show all

RPS Conference 2010, Abstracts 2010 - Royal Pharmaceutical Society

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?